Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 10 2020
21 10 2020
Historique:
received:
16
01
2020
accepted:
27
08
2020
entrez:
22
10
2020
pubmed:
23
10
2020
medline:
10
4
2021
Statut:
epublish
Résumé
Novel N-phenylindazole based diarylureas have been designed, synthesized and evaluated as potential anticancer agents. In vitro cell viability studies of these derivatives illustrate good potency with IC
Identifiants
pubmed: 33087745
doi: 10.1038/s41598-020-74572-1
pii: 10.1038/s41598-020-74572-1
pmc: PMC7578069
doi:
Substances chimiques
Amides
0
Antineoplastic Agents
0
Urea
8W8T17847W
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17969Références
Clin Cancer Res. 2010 Dec 15;16(24):5923-7
pubmed: 21059813
Molecules. 2018 Oct 26;23(11):
pubmed: 30373212
Angiogenesis. 2017 May;20(2):185-204
pubmed: 28361267
Anticancer Res. 2017 Sep;37(9):4919-4926
pubmed: 28870913
Cardiooncology. 2019 Apr 25;5:2
pubmed: 32154009
J Med Chem. 2014 Jul 24;57(14):5845-59
pubmed: 24471928
Int J Cancer. 2011 Jul 1;129(1):245-55
pubmed: 21170960
Int J Cancer. 2014 Sep 15;135(6):1487-96
pubmed: 24347491
Clin Cancer Res. 2014 Jul 1;20(13):3472-84
pubmed: 24763611
Sci Rep. 2019 Dec 4;9(1):18266
pubmed: 31797891
Clin Cancer Res. 2008 Nov 15;14(22):7272-83
pubmed: 19010843
Curr Med Chem. 2016;23(15):1528-48
pubmed: 27063259
Drugs R D. 2011;11(2):113-26
pubmed: 21679004
Exp Ther Med. 2010 Sep;1(5):863-866
pubmed: 22993610
Mol Cancer Ther. 2008 Oct;7(10):3129-40
pubmed: 18852116
Int J Hepatol. 2011;2011:490463
pubmed: 22164336
Onco Targets Ther. 2015 Oct 15;8:2949-57
pubmed: 26508880
J Clin Oncol. 2010 Feb 20;28(6):1061-8
pubmed: 20100962
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Exp Mol Med. 2019 Sep 24;51(9):1-15
pubmed: 31551425
Anticancer Res. 2014 Nov;34(11):6417-22
pubmed: 25368241
Liver Cancer. 2017 Jun;6(3):216-226
pubmed: 29234628
BMC Cancer. 2010 Oct 15;10:560
pubmed: 20950443
Anticancer Res. 2015 Mar;35(3):1803-8
pubmed: 25750346
Biomed Res Int. 2019 Feb 18;2019:4650695
pubmed: 30906773
J Med Chem. 2014 Dec 26;57(24):10257-74
pubmed: 25255204
ChemMedChem. 2018 Aug 10;13(15):1490-1507
pubmed: 29863292
Anticancer Agents Med Chem. 2018;18(9):1228-1234
pubmed: 29745343
J Clin Oncol. 2005 Aug 20;23(24):5474-83
pubmed: 16027439
Mol Cancer Ther. 2007 Jul;6(7):2012-21
pubmed: 17620431
J Clin Oncol. 2008 Oct 10;26(29):4708-13
pubmed: 18541897
Nature. 2015 Mar 5;519(7541):102-5
pubmed: 25686603
J Clin Oncol. 2014 Oct 20;32(30):3374-82
pubmed: 25225436
PLoS One. 2018 Jul 26;13(7):e0200878
pubmed: 30048489
Jpn J Clin Oncol. 2013 Jun;43(6):616-28
pubmed: 23630366
J Vis Exp. 2014 Sep 01;(91):e51312
pubmed: 25225985
Mol Med Rep. 2018 Aug;18(2):2335-2341
pubmed: 29956798
J Med Chem. 2017 Mar 9;60(5):1638-1647
pubmed: 27935308
Clin Cancer Res. 2012 Oct 15;18(20):5662-71
pubmed: 22929805